Title:
がんの予後診断及び治療のための方法及び組成物
Document Type and Number:
Japanese Patent JP7325463
Kind Code:
B2
Abstract:
The invention provides methods of using expression levels of one or more immune cell gene signatures and/or combinations of immune cell gene signatures as selection criteria for selecting a patient having cancer for treatment with an immunotherapy. The invention further provides methods for selecting a patient having cancer who may benefit from a particular immunotherapy, such as an activating immunotherapy or a suppressing immunotherapy and administering to the patient the activating immunotherapy or suppressing immunotherapy to treat the cancer.
Inventors:
Molinero, Luciana
Hegre, Priddy
Hegre, Priddy
Application Number:
JP2021031306A
Publication Date:
August 14, 2023
Filing Date:
March 01, 2021
Export Citation:
Assignee:
Genentech, Incorporated
International Classes:
C12Q1/6886; A61K45/00; A61P35/00; A61P37/02; G01N33/53
Domestic Patent References:
| JP2014525918A |
Attorney, Agent or Firm:
Sonoda & Kobayashi Patent Attorneys Corporation
Previous Patent: game machine
Next Patent: Macrocycles as Factor XIA Inhibitors with Heterocyclic P2' Groups
Next Patent: Macrocycles as Factor XIA Inhibitors with Heterocyclic P2' Groups